BioSpace News Archive

EyePoint Pharmaceutical, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, March 3, 2022 to report its fourth quarter and full-year 2021 financial results and highlight recent corporate developments.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for genetically defined diseases, reported business highlights and financial results for the fourth quarter and year ended Dec. 31, 2021.

The global veterinary dental equipment market is anticipated to touch new heights in the near future.

Gel warmers are widely used to maintain and balance the body temperature of a patient and during ultrasound procedure.

Extensive research and development activities carried in drug development have given a significant boost in the global injectable nanomedicines market.

In the decades gone by, populations expanded uncontrollably as sex or intercourse formulates an important activity for humanity but there were no measures to refrain from pregnancy when not desired.

Cardiovascular diseases include a number of heart diseases such as congenital heart disease, coronary artery disease, and arrhythmias.

argenx announced that it will host a conference call and audio webcast on Thursday, March 3, 2022 at 2:30 pm CET to discuss its full year 2021 financial results and provide a fourth quarter business update.

Saniona received SEK 7.3 million (US$0.8 million) from Novartis related to Novartis’s January 2021 acquisition of Cadent Therapeutics, in which Saniona held a 3% ownership stake.

Vimian Group AB will publish its Interim Report for the period of January-December 2021 on Thursday, 10 March 2022, at 07.45.